lifestyle.thedishh.com

Author: ImageneBio, Inc.

ImageneBio Announces $30 Million Private Placement

May 2, 2026
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 29, 2026
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

April 28, 2026
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

February 10, 2026